Schlagwörter
AL AMYLOIDOSIS
3
BORTEZOMIB
3
CHEMOTHERAPY
3
CYCLOPHOSPHAMIDE
3
LENALIDOMIDE
3
MAINTENANCE
3
MULTIPLE-MYELOMA
3
NATRIURETIC PEPTIDE
3
PRIMARY SYSTEMIC AMYLOIDOSIS
3
SURVIVAL
3
AL amyloidosis
1
CRITERIA
1
Dosing
1
EFFICACY
1
IMPROVED OUTCOMES
1
Internal Medicine
1
JAK2 inhibitor
1
LIGHT-CHAIN AMYLOIDOSIS
1
MANAGEMENT
1
MELPHALAN
1
MULTICENTER
1
OPEN-LABEL
1
POLYCYTHEMIA-VERA
1
Platelet count
1
STAGING SYSTEM
1
STEM-CELL TRANSPLANTATION
1
Safety
1
THERAPY
1
Treatment
1
prognosis
1
survival
1
time trend
1